Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Al B. Benson, Alan P. Venook(University of Wisconsin Carbone Cancer Center), Mahmoud M. Al-Hawary, Lynette Cederquist, Yi‐Jen Chen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Kristen K. Ciombor(University of Wisconsin Carbone Cancer Center), Stacey A. Cohen(University of Wisconsin Carbone Cancer Center), Harry S. Cooper, Dustin A. Deming, Paul F. Engstrom(University of Wisconsin Carbone Cancer Center), Jean L. Grem(University of Wisconsin Carbone Cancer Center), Axel Grothey(University of Wisconsin Carbone Cancer Center), Howard S. Höchster(University of Wisconsin Carbone Cancer Center), Sarah E. Hoffe, Steven R. Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi(University of Wisconsin Carbone Cancer Center), Wells A. Messersmith(University of Wisconsin Carbone Cancer Center), Jeffrey A. Meyerhardt(University of Wisconsin Carbone Cancer Center), Mary F. Mulcahy(University of Wisconsin Carbone Cancer Center), James D. Murphy(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Steven Nurkin(Barnes-Jewish Hospital), Leonard B. Saltz(University of Wisconsin Carbone Cancer Center), Sunil Sharma(University of Wisconsin Carbone Cancer Center), David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass
Cited by 137Open Access
Abstract
The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.
Related Papers
No related papers found
Powered by citation graph analysis